Tearing Down Scientific Boundaries: Frontiers in Medicinal Chemistry 2026

IF 3.5 4区医学 Q2 CHEMISTRY, MEDICINAL

ChemMedChem Pub Date : 2026-09-13 DOI:10.1002/cmdc.70490

Pascal Heitel, Philipp Barbie, Alessia Gambardella, Marta Pinto, Felix Pape, Anika Tarasewicz, Gerhard Hessler, Bernhard Wünsch, Matthias Schiedel, Christina Lamers

引用次数: 0

Abstract

The Frontiers in Medicinal Chemistry (FiMC) was held in Münster from March 24^th to 27^th as the largest international Medicinal Chemistry conference in Germany. Welcoming more than 240 participants from around 20 countries, it was a vibrant conference, celebrating the community and the Medicinal Chemistry division of the German Chemical Society (GDCh). The program filled 4 days with over 40 lectures from industry and academia, and 125 posters. Herein, the NextGenMedChem group reports their highlights from this conference.

查看原文本刊更多论文

打破科学界限：药物化学前沿2026

FiMC （Frontiers in Medicinal Chemistry）是德国最大的国际药物化学会议，于3月24日至27日在德国慕尼黑举行。这是一场充满活力的会议，欢迎来自约20个国家的240多名与会者，庆祝德国化学学会（GDCh）的社区和药物化学部门。为期4天的活动中，有40多场来自产业界和学术界的讲座，以及125张海报。在此，NextGenMedChem小组报告了他们在本次会议上的亮点。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

ChemMedChem 医学-药学

CiteScore

6.70

自引率

2.90%

发文量

280

审稿时长

1 months

期刊介绍： Quality research. Outstanding publications. With an impact factor of 3.124 (2019), ChemMedChem is a top journal for research at the interface of chemistry, biology and medicine. It is published on behalf of Chemistry Europe, an association of 16 European chemical societies. ChemMedChem publishes primary as well as critical secondary and tertiary information from authors across and for the world. Its mission is to integrate the wide and flourishing field of medicinal and pharmaceutical sciences, ranging from drug design and discovery to drug development and delivery, from molecular modeling to combinatorial chemistry, from target validation to lead generation and ADMET studies. ChemMedChem typically covers topics on small molecules, therapeutic macromolecules, peptides, peptidomimetics, and aptamers, protein-drug conjugates, nucleic acid therapies, and beginning 2017, nanomedicine, particularly 1) targeted nanodelivery, 2) theranostic nanoparticles, and 3) nanodrugs. Contents ChemMedChem publishes an attractive mixture of: Full Papers and Communications Reviews and Minireviews Patent Reviews Highlights and Concepts Book and Multimedia Reviews.